Ravinder K Grewal Selected Research

Iodine-124

1/2022	Enhancing Radioiodine Incorporation in BRAF-Mutant, Radioiodine-Refractory Thyroid Cancers with Vemurafenib and the Anti-ErbB3 Monoclonal Antibody CDX-3379: Results of a Pilot Clinical Trial.
1/2017	Redifferentiating Thyroid Cancer: Selumetinib-enhanced Radioiodine Uptake in Thyroid Cancer.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Ravinder K Grewal Research Topics

Disease

16	Thyroid Neoplasms (Thyroid Cancer) 01/2022 - 02/2006
15	Neoplasms (Cancer) 07/2022 - 09/2002
8	Neoplasm Metastasis (Metastasis) 07/2019 - 02/2006
3	Papillary Thyroid Cancer 07/2014 - 09/2012
2	Prostatic Neoplasms (Prostate Cancer) 07/2022 - 05/2006
2	Neuroendocrine Tumors (Neuroendocrine Tumor) 01/2022 - 02/2018
1	Chondroma (Enchondroma) 01/2019
1	Carcinoid Tumor (Carcinoid) 01/2019
1	medullary Thyroid cancer 02/2018
1	Oncogenic osteomalacia 09/2016
1	Lymphatic Metastasis 07/2014
1	Carcinoma (Carcinomatosis) 09/2012
1	Disease Progression 09/2012
1	Osteonecrosis (Kienbock's Disease) 01/2011
1	Breast Neoplasms (Breast Cancer) 02/2010
1	Bone Diseases (Bone Disease) 02/2010
1	Dysgeusia (Parageusia) 10/2009
1	Pain (Aches) 10/2009
1	Thyroid Nodule (Nodule, Thyroid) 11/2007
1	Rhabdomyosarcoma 01/2007
1	Spontaneous Fractures (Pathological Fracture) 05/2006
1	Osteoporosis 05/2006
1	Metabolic Bone Diseases (Osteopenia) 05/2006
1	Gastroesophageal Reflux (GERD) 01/2005
1	Heart Failure 01/2004
1	Coronary Artery Disease (Coronary Atherosclerosis) 01/2004
1	Hodgkin Disease (Hodgkin's Disease) 11/2002
1	Solitary Pulmonary Nodule 09/2002

Drug/Important Bio-Agent (IBA)

9	IodineIBA 01/2022 - 07/2007
4	Thyroglobulin FDA Link 01/2019 - 02/2006
3	Somatostatin Receptors (Somatostatin Receptor)IBA 01/2022 - 09/2002
3	Thyrotropin Alfa FDA LinkGeneric 01/2022 - 10/2009
2	Lutetium-177IBA 07/2022 - 01/2022
2	VemurafenibIBA 01/2022 - 01/2019
2	Mitogen-Activated Protein KinasesIBA 01/2022 - 02/2013
2	Iodine-124IBA 01/2022 - 01/2017
2	Edotreotide (SMT 487)IBA 01/2019 - 09/2016
2	Iodine-131IBA 01/2017 - 07/2007
2	Mitogen-Activated Protein Kinase Kinases (MEKs)IBA 01/2017 - 02/2013
2	AZD 6244IBA 01/2017 - 02/2013
2	Diphosphonates (Bisphosphonates)IBA 01/2011 - 02/2010
1	177Lu-PSMA-617IBA 07/2022
1	taxaneIBA 07/2022
1	AntigensIBA 07/2022
1	Proteins (Proteins, Gene)FDA Link 07/2022
1	Androgen Receptors (Androgen Receptor)IBA 07/2022
1	Receptor Protein-Tyrosine Kinases (Tyrosine Kinase Receptors)IBA 01/2022
1	Monoclonal AntibodiesIBA 01/2022
1	Sucrose (Saccharose)IBA 01/2022
1	Phosphotransferases (Kinase)IBA 07/2019
1	Ga(III)-DOTATOCIBA 01/2019
1	Somatostatin (Somatotropin Release-Inhibiting Factor)IBA 02/2018
1	gallium Ga 68 dotatateIBA 02/2018
1	Tyrosine Kinase InhibitorsIBA 01/2017
1	Glucose (Dextrose)FDA LinkGeneric 05/2015
1	prolinedithiocarbamate (PDTC)IBA 05/2015
1	Fluorodeoxyglucose F18 (Fludeoxyglucose F 18)FDA Link 10/2013
1	sodium-iodide symporter (sodium iodide symporter)IBA 02/2013
1	methylene diphosphonateIBA 02/2010
1	Technetium (Technetium 99m)IBA 02/2010
1	AndrogensIBA 05/2006
1	Aromatase InhibitorsIBA 05/2006
1	Deoxyglucose (2 Deoxy D glucose)IBA 02/2006
1	AntacidsIBA 01/2005
1	Thallium-201IBA 11/2002
1	technetium Tc 99m depreotide (Tc-99m depreotide)IBA 09/2002
1	Peptides (Polypeptides)IBA 09/2002
1	somatostatin receptor 2IBA 09/2002

Therapy/Procedure

16	Therapeutics 07/2022 - 11/2002
5	Thyroidectomy 03/2016 - 11/2007
4	Drug Therapy (Chemotherapy) 07/2022 - 01/2005
2	Radiotherapy 07/2019 - 01/2019
1	Castration 07/2022
1	Adrenalectomy 12/2020
1	Craniotomy 07/2019
1	Precision Medicine 01/2017
1	Cryosurgery 09/2016
1	Neck Dissection (Radical Neck Dissection) 07/2014